Novel BACE1 inhibitors with a non-acidic heterocycle at the P1′ position

Add time:08/08/2019    Source:sciencedirect.com

We have reported potent peptidic and non-peptidic BACE1 inhibitors with a hydroxymethylcarbonyl (HMC) isostere as a substrate transition-state mimic. However, our potent inhibitors possess a tetrazole ring at the P1′ position. It is desirable that central nervous system (CNS) drugs do not possess an acidic moiety. In this study, we synthesized non-acidic BACE1 inhibitors with heterocyclic derivatives at the P1′ position. KMI-1764 (27) exhibited potent inhibitory activity (IC50 = 27 nM). Interestingly, these non-acidic inhibitors tended to follow the quantitative structure–activity relationship (QSAR) equation and interacted with BACE1-Arg235 in the binding model.

We also recommend Trading Suppliers and Manufacturers of 2-bromo-4-phenylbutyric acid (cas 16503-46-1). Pls Click Website Link as below: cas 16503-46-1 suppliers

Prev:Exploring the synthetic applicability of a new carboxylic acid reductase from Segniliparus rotundus DSM 44985
Next:Total determination of triclabendazole and its metabolites in bovine tissues using liquid chromatography-tandem mass spectrometry)